Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?
Maarten Criel, Maarten Falter, Jasmien Jaeken, Margaretha Van Kerrebroeck, Isabelle Lefere, L Meylaerts, Dieter Mesotten, Margot Vander Laenen, Tom Fivez, Michiel Thomeer, David Ruttens
Abstract
<b>Insidious</b><b>venous thromboembolism (VTE) is mainly a problem in ICU-ventilated SARS-CoV-2 patients, while patients in the general ward, treated with thromboprophylaxis (0.5 mg·kg<sup>−1</sup>), had a low incidence of insidious VTE</b>https://bit.ly/2Yl8jft
Topics & Concepts
MedicineVenous thromboembolismIncidence (geometry)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakIntensive care medicineEmergency medicineInternal medicineThrombosisVirologyDiseaseInfectious disease (medical specialty)OutbreakOpticsPhysicsVenous Thromboembolism Diagnosis and ManagementCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impacts